Literature DB >> 16570202

Renal amyloidosis in a child with sickle cell anemia.

Behçet Simşek1, Aysun K Bayazit, Melek Ergin, Mustafa Soran, Hasan Dursun, Yurdanur Kilinc.   

Abstract

The kidney is frequently affected in patients with sickle cell syndrome, i.e., homozygous and heterozygous patients, with a consequently large spectrum of renal abnormalities that may range from minimal functional changes to chronic renal failure. Here, we present a 13-year-old boy with sickle cell anemia (SCA) (HbSS) who was referred to our unit with nephrotic syndrome. Renal biopsy revealed AA type amyloidosis on the basis of light microscopic findings, indicating Congo red staining and immunohistochemistry. He had neither a family history of familial Mediterranean fever (FMF) nor any complaint of recurrent abdominal pain, arthritis, and fever, but frequent painful vaso-occlusive crises. The patient was found to have no MEFV gene (Mediterranean feVer) mutations either. Painful episodic attacks might provoke recurrent acute inflammation, leading to repeated stimulation of acute phase responses and cause secondary amyloidosis. To our knowledge, this boy is the first case of SCA complicated by renal amyloidosis observed in childhood.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16570202     DOI: 10.1007/s00467-006-0069-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  11 in total

1.  Regression of nephrotic syndrome due to amyloidosis secondary to familial mediterranean fever following colchicine treatment.

Authors:  B Simşek; I Işlek; T Simşek; S Küçüködük; K Cengiz
Journal:  Nephrol Dial Transplant       Date:  2000-02       Impact factor: 5.992

2.  Renal amyloidosis in a patient with homozygous sickle cell anemia and M694V/M694V mutation.

Authors:  H Akar; K Keven; G Nergizoglu; S Erturk; K Ates; B Erbay; N Akar; N Duman; O Karatan
Journal:  Nephron       Date:  2000-11       Impact factor: 2.847

3.  Regression of nephrotic syndrome in amyloidosis of familial mediterranean fever following colchicine treatment.

Authors:  A Livneh; S Shtrasburg; P Langevitz
Journal:  Nephrol Dial Transplant       Date:  2000-10       Impact factor: 5.992

Review 4.  Renal abnormalities in sickle cell disease.

Authors:  K I Ataga; E P Orringer
Journal:  Am J Hematol       Date:  2000-04       Impact factor: 10.047

5.  Different glomerular pathologies in sickle cell anemia.

Authors:  M Balal; S Paydas; N Seyrek; I Karayaylali
Journal:  Clin Nephrol       Date:  2004-11       Impact factor: 0.975

6.  Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease.

Authors:  J Stuart; P C Stone; N O Akinola; J R Gallimore; M B Pepys
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

7.  Secondary amyloidosis accompanying multiple sickle cell crises.

Authors:  N Win; M Brozović; R Gabriel
Journal:  Trop Doct       Date:  1993-01       Impact factor: 0.731

Review 8.  Renal complications of sickle cell disease: managing for optimal outcomes.

Authors:  Luciana de Santis Feltran; João Thomás de Abreu Carvalhaes; Ricardo Sesso
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Criteria for the diagnosis of familial Mediterranean fever.

Authors:  A Livneh; P Langevitz; D Zemer; N Zaks; S Kees; T Lidar; A Migdal; S Padeh; M Pras
Journal:  Arthritis Rheum       Date:  1997-10

10.  Cellular management of iron in the brain.

Authors:  J R Connor; S L Menzies
Journal:  J Neurol Sci       Date:  1995-12       Impact factor: 3.181

View more
  3 in total

1.  Secondary renal amyloidosis in a 13-year-old girl with bronchiectasis.

Authors:  Eun Ae Yang; Dong Won Lee; Myung Chul Hyun; Min Hyun Cho
Journal:  Korean J Pediatr       Date:  2010-07-31

Review 2.  Renal amyloidosis in children.

Authors:  Yelda Bilginer; Tekin Akpolat; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2011-03-01       Impact factor: 3.714

3.  Sickle cell disease: a case report of renal amyloidosis.

Authors:  Ann Bugeja; Paula Blanco; Edward G Clark; Manish M Sood
Journal:  BMC Nephrol       Date:  2018-10-10       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.